GROUP ONE TRADING, L.P. - AVADEL PHARMACEUTICALS PLC ownership

AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 45 filers reported holding AVADEL PHARMACEUTICALS PLC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of AVADEL PHARMACEUTICALS PLC
ValueSharesWeighting
Q3 2023$63,685
-80.1%
6,183
-68.2%
0.00%
-100.0%
Q2 2023$319,976
-69.1%
19,416
-82.8%
0.00%
-75.0%
Q1 2023$1,034,778
+441.7%
112,967
+323.5%
0.00%
Q4 2022$191,007
-55.2%
26,677
-57.3%
0.00%
Q1 2022$426,000
-21.8%
62,423
-7.4%
0.00%
Q4 2021$545,000
-16.9%
67,447
+0.8%
0.00%
-100.0%
Q3 2021$656,000
+365.2%
66,888
+216.8%
0.00%
Q4 2020$141,000
-39.7%
21,113
-54.5%
0.00%
-100.0%
Q3 2020$234,000
+1200.0%
46,443
+635.9%
0.00%
Q2 2019$18,000
+800.0%
6,311
+282.7%
0.00%
Q1 2019$2,000
-92.6%
1,649
-84.1%
0.00%
Q4 2018$27,000
-75.9%
10,349
-59.4%
0.00%
-100.0%
Q3 2018$112,000
-8.9%
25,482
+27.1%
0.00%0.0%
Q2 2018$123,000
-48.3%
20,049
-38.7%
0.00%
-50.0%
Q1 2018$238,000
+235.2%
32,715
+280.0%
0.00%
Q4 2017$71,0008,6090.00%
Other shareholders
AVADEL PHARMACEUTICALS PLC shareholders Q2 2019
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 1,625,000$12,269,0003.04%
GENDELL JEFFREY L 1,146,764$8,658,0001.11%
Broadfin Capital, LLC 1,029,012$7,769,0001.04%
RTW INVESTMENTS, LP 3,401,434$25,681,0000.97%
BRANDES INVESTMENT PARTNERS, LP 3,651,948$27,571,0000.66%
Aristides Capital LLC 71,520$540,0000.42%
Tekla Capital Management LLC 814,588$6,150,0000.23%
INVESTORS ASSET MANAGEMENT OF GEORGIA INC /GA/ /ADV 36,100$273,0000.17%
Leap Investments LP 43,481$328,0000.15%
Brown Capital Management 1,829,886$13,816,0000.13%
View complete list of AVADEL PHARMACEUTICALS PLC shareholders